Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration.
A method for measuring cellular concentrations of the anthracycline doxorubicin was developed. The assay involves cell lysis and protein degradation by detergent and proteinase K treatment followed by DNA hydrolysis using DNase I. Prior to high-performance liquid chromatography, samples are deproteinized by the addition of ZnSO4 and methanol. The assay is linear with respect to both the cellular drug content and the number of cells assayed over the ranges tested, and drug recovery is close to 100%. The method has a limit of detection of 50 fmol injected doxorubicin. Within run and between-day coefficients of variation have consistently been found to be in the 5% and 10% range, respectively, in different cell lines exposed to doxorubicin in vitro. The method has been evaluated in analyses of doxorubicin levels in mononuclear blood cells of patients. The assay offers several advantages over commonly used organic extraction techniques and may improve cellular drug monitoring during anthracycline therapy in patients.
Andersen
A
A
Department of Clinical Pharmacology, Norwegian Radium Hospital, Oslo.
Warren
D J
DJ
Slørdal
L
L
D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D003850:Deoxyribonuclease I; D004317:Doxorubicin / Q000032:analysis* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019286:Endopeptidase K; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D012697:Serine Endopeptidases; D014407:Tumor Cells, Cultured
D004317:Doxorubicin; D003850:Deoxyribonuclease I; D012697:Serine Endopeptidases; D019286:Endopeptidase K